宏利(00945.HK)首季核心盈利按年跌33.6%至10.3億加元 派息0.28加元
宏利(00945.HK)公布3月底止首季業績,核心盈利按年倒退33.6%至10.28億加元,每股普通股攤薄盈利0.64加元。季內歸於股東之收入淨額按年倒退40.4%至12.96億加元。公司並宣派每股普通股0.28加元。
首季新業務價值倒退9.6%至4.69億加元,年度化保費等值銷售總額按年倒退8%至16.01億加元。財富與資產管理業務淨流入32億加元,去年同期則錄得13億加元淨流出。
季內宏利人壽保險公司LICAT資本比率155%,高於去年同期之144%。財務槓桿比率23%,低於去年同期的27%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.